Skip to main content
BMJ Open Respiratory Research logoLink to BMJ Open Respiratory Research
. 2023 Jul 21;10(1):e001589. doi: 10.1136/bmjresp-2022-001589

Chemical exposure and alveolar macrophages responses: ‘the role of pulmonary defense mechanism in inhalation injuries’

Mahtab Tapak 1,2, Somaye Sadeghi 3, Tooba Ghazanfari 4,5, Nariman Mosaffa 1,
PMCID: PMC10364189  PMID: 37479504

Abstract

Epidemiological and clinical studies have indicated an association between particulate matter (PM) exposure and acute and chronic pulmonary inflammation, which may be registered as increased mortality and morbidity. Despite the increasing evidence, the pathophysiology mechanism of these PMs is still not fully characterised. Pulmonary alveolar macrophages (PAMs), as a predominant cell in the lung, play a critically important role in these pathological mechanisms. Toxin exposure triggers events associated with macrophage activation, including oxidative stress, acute damage, tissue disruption, remodelling and fibrosis. Targeting macrophage may potentially be employed to treat these types of lung inflammation without affecting the natural immune response to bacterial infections. Biological toxins, their sources of exposure, physical and other properties, and their effects on the individuals are summarised in this article. Inhaled particulates from air pollution and toxic gases containing chemicals can interact with alveolar epithelial cells and immune cells in the airways. PAMs can sense ambient pollutants and be stimulated, triggering cellular signalling pathways. These cells are highly adaptable and can change their function and phenotype in response to inhaled agents. PAMs also have the ability to polarise and undergo plasticity in response to tissue damage, while maintaining resistance to exposure to inhaled agents.

Keywords: oxidative stress, airway epithelium, allergic lung disease

Introduction

Undoubtedly, the inhalation of airborne toxicants is a significant international health issue.1 According to the WHO, air pollution exposure is responsible for over seven million deaths annually throughout the world.2 Rising air pollution levels are associated with increased mortality/hospital admissions in individuals suffering from respiratory diseases.3 Toxicity of air pollution includes not only gaseous components, but also particulate matter (PM). PM is the main cause of air pollution exposure’s adverse effects that composes of suspended solid fragments and a fluid droplet of biological compounds, organic chemicals, metals, acids and airborne dust.4 The origins of PM typically include road construction, farming, smokestacks and forest fires. However, most particles are formed from the conversion of gaseous precursors, like SO2 and NOx, generated by industries, solid fuels, combustion and automobile traffic.1 5

The human respiratory tract is continuously challenged by infectious and non-infectious stimuli including PM.6 Components of pollutants, stimulate cells through a vast array of recognising mechanisms including Toll-like receptors, and polyaromatic hydrocarbon (PAH) sensing pathways such as the aryl hydrocarbon receptor (AhR) and reactive oxygen species (ROS) sensing pathways.7 NF-κB and MAPK pathways as a proinflammatory intracellular signalling cascade are in turn activated.8 Exposure to toxins through skin/eye contact, and/or swallowing particularly inhalation in the form of aerosols or dust (in occupation and environments) can lead to severe destruction of the airways, even death, and compromise the respiratory system’s function9 10; hence, a coordinated and fast-acting lung immune system is required to control detrimental microbial and environmental pollutants and maintenance of homeostasis.6 Understanding and extracting biochemical pathways activated through exposure to various inhaled toxicants, such as ricin, silica and cannabis, may help us identify potential therapeutic targets that are susceptible to anti-inflammatory treatments.

Lung inflammation is caused by various cell types, including alveolar macrophages (AMs), in response to airborne stimuli and inhaled toxins. AMs act as the first line of defence and play a vital role in coordinating the initiation and resolution of the inflammatory response in the lungs.11–13 Long-term exposure to external stimulation induces a severe immune response, leading to the release of cytokines and chemokines and the recruitment of inflammatory cells. Exposure to PM leads to the production of ROS and enzymes, indicating oxidative stress as a common mechanism of damage. Both oxidative stress and inflammation contribute to respiratory diseases by causing alveolar destruction.14–16

At present, there is no definite cure or effective treatment for severe lung inflammation caused by biotoxins. Some studies have summarised the lung inflammation following exposure to cigarette smoke, mycotoxins and ricin.11 However, to fully understand the effective mechanism of biotoxins on lung inflammation, more investigations are needed. The current review aimed to summarise the current state of knowledge regarding biological toxins. Investigating the effects of chemical exposures on the immune system’s response through AMs can help find solutions for treating damages caused by toxic exposure. This approach can help identify common pathways, enabling the identification of therapeutic targets for anti-inflammatory treatments. Ultimately, this will lead to the design of effective strategies for successfully treating acute and chronic lung inflammation.

Inhalation toxins

Toxins, as defined in modern terms, are the metabolic products of poisons from bacteria, plants, animals and fungi that can be found in nature or produced through chemical/biotechnological means. Gases and vapours are commonly inhaled substances, while liquids and solids can be inhaled in the form of fine mist, airborne particles or dusts. This may cause irritated lung damage, suffocation or other systemic effects and acute inhalation damage.10 In this section, the absorption process of toxins, that cause lung damage through inhalation, was summarised.

Diesel exhaust particles

Inadequate combustion of fossil fuel from diesel vehicles leads to generate DE particles (DEP) which is a combination of three gases (NO, CO, NO2) and DEP.17 DEP is composed of halogenated aromatic hydrocarbons, PAHs and quinones with active oxidation, metals such as Fe and Ca, and many other organic components.18 After inhalation, DEP is deposited in the lungs and absorbed by AM and pulmonary epithelial cells.19 20

PAH binds to the cytosolic AhR,21 which leads to the induction of cytochrome-P450, a metabolising enzyme that transforms toxicants into intermediates with greater toxicity. This induction results in the generation of excessive ROS and oxidative stress,22 which stimulates the release of CCL2 and CXCL8 by AMs. This, in turn, leads to the recruitment of cytotoxic-T-lymphocytes and neutrophils, with an enhancement in the generation of oxygen-free radicals that intensify the destruction of the AMs and ultimately result in chronic lung disorders.21

Ricin

Ricin, derived from the castor bean plant Ricinus Communis, is the most toxic phytotoxin and category B agent under the Biological and Toxins Weapons Convention (BTWC). Ricin is a type II protein that can inactivate ribosomes.22 It comprises two subunits: Ricin’s A subunit (RTA) and Ricin’s B subunit (RTB). RTA, with toxic moiety, cleaves 28S-rRNA and hinders the binding of elongation factor 2, leading to cessation of protein synthesising and triggering apoptosis. RTB, also, with a lectin moiety, transports ricin into cells via glycolipids/glycoproteins.23 A single RTA can inactivate nearly 1500 ribosomes per minute, preventing the cell from compensating for the loss.24

The first cells to encounter ricin in the pulmonary system are AMs, which attach to the mannosylated B-chain of ricin via a mannose receptor (MR;CD206) on its surface.25 As soon as ricin is up-taken by AMs, they undergo apoptosis, which leads to invocation of inflammatory cells to the lungs.26 Cells undergo mitochondrial changes after exposure to ricin, because of production of ROS, leading to activation of the internal apoptotic pathway or mitochondrial pathway.27 28 So, inhalation of aerosolised ricin can lead to acute lung injuries (ALIs) and symptoms resembling acute respiratory distress syndrome (ARDS).29

Cannabis

Cannabis oil extract or other cannabinoids are highly lipophilic molecules taken from marijuana plant (one of the most popularly smoked materials after tobacco).30 31 Marijuana smoke contains many suspended particles including phenols, aldehydes, acrolein, benzpyrene, benzanthracene and the major psychoactive ingredient named delta-9-tetrahydrocannabinol (THC) that all are so harmful for pulmonary system.32

Cannabinoid receptors-1 and 2 (CB1,2) are the main receptors that are connected to cognate cannabinoid, which activate the Gi/oα subunit to inhibit adenylate-cyclase activity. This, in turn, reduces cAMP and Protein Kinase A activity.33 THC, as a major psychoactive-immunosuppressive ingredient in marijuana, acts via CB2 receptors that expressed on thymus, tonsils and immune cells.31 CB1 and CB2 regulate macrophages’ activity in different ways. So, ROS, generated by CB1 via the pathway of p38-MAPK, produces proinflammatory cytokines consecutively, whereas CB1-induced ROS are negatively regulated through the activation of Rap1 mediated by CB2.34

Silica

Two forms of silica include: (1) crystalline silica (CS), which is available in substances derived from Earth’s crust; and (2) amorphous silica, which is used in semiconductor circuits.35 Industrial workers who are exposed for long durations to excessive inhalation of CS are at an increased risk of respiratory diseases, which is associated with lung inflammation and fibrosis.36

As the first intrinsic cell in the lung, AMs bind to inhaled CS via collagen-structured macrophage receptor (MARCO) and scavenger receptors (SR)-AI and SR-AII.37 38 They undergo phagosome interactions with the endolysosome system and activation of the inflammasome cascade.37 38

AMs that survive after encountering silica migrate out of the pulmonary via either the proximal lymph nodes or mucociliary escalator. However, if they stay in the lung, AMs are recruited to the tissue space and shift to activated interstitial macrophage (IM) that are responsible for pathogenesis.39

If AMs, which have ingested silica particles through scavenger receptors, are not cleared from the lung, then ROS are induced and cause damage to AM lysosomes. This damage results in the leaking of the contents of the lysosome into the cytoplasm, which leads to the formation of a multiprotein complex, called the active inflammasome. This complex then leads to the release of IL-1β and the recruitment of more inflammatory cells, initiating an inflammatory response that results in lung damage.40

Smoke

Elemental carbon components are found in smoke resulting from burning materials such as tobacco.41 The toxic compounds of smoke include irritants with solubility in water such as CO, HCN, acrylonitrile and Phosgene (which is slightly soluble in water).42 43

Smoke inhalation leads to thermal/chemical damages to cilia and airway epithelial cells and release of proinflammatory cytokines from activated neutrophils, lung capillary endothelial cells and macrophages, and consequently results in the synthesis of ROS and the production of a large amount of NO and finally an inflammatory response.44

Hydrogen chloride (HCl) and chlorine

Cl2 and hydrogen (H2) gases can combine directly to form HCl, a toxic light yellow gas with harsh odour. Because of its acidity and water solubility, HCl extremely irritates the mucosa of the nose, throat and respiratory tract.42 45 46 The characteristic of lung damage caused by HCl and Cl2 is reactive airways dysfunction syndrome.46 47

Further oxidative damage of Cl2 and hypochlorous acid to airways occur by recruitment and activation of macrophages, granulocytes, epithelial cells and subsequent induction of iNOS, ROS and a high quantity of fibrinogen, adiponectin, SAP (serum-amyloid-P) and sVCAM-1 (soluble-vascular cell adhesion molecule-1) in bronchoalveolar lavage fluid (BALF) and airway epithelium.47–49

Chlorine exposure can lead to mitochondrial dysfunction, resulting in the excessive production of ROS, which is the main cause of cellular and organ injury, including damage to mitochondrial DNA, the formation of MPT pore and apoptosis.50 51 Myeloperoxidase increases the formation of reactive oxygen mediators and exacerbates chlorine-induced damages. Therefore, MPO is an important therapeutic target for diseases with inflammation manifestations.47

Phosgene (carbonyl chloride)

Phosgene (COCl2) has a sweetish and pleasant odour of mown grass with lipophilic properties.52 53 Because of its low water solubility, its reaction rate with mucus layer and irritation in the upper airway is low, while its lipophilic properties cause a rapid inhibition by surfactant nucleophiles.52 53 Nonetheless, the absence of quick sign and recognisable odour aggravates its toxicity.54 The source of phosgene is chlorinated hydrocarbons combustion (like welding and fires) and the synthesis of solvents (such as degreasers, cleaners).55

Once phosgene penetrates to pulmonary, it interacts with surfactant and then nucleophilic groups like amino, hydroxyl, sulfhydryl part of proteins, lipids and nucleic acids are acrylated. This causes the disruption of the surfactants which in turn leads to pulmonary oedema.54 Moreover, heterolytic/homolytic segregation of phosgene produces extreme reactive carbamoyl-monochloride-radicals, which are responsible for transformation and impairment of phospholipids and proteins, as well as the increased production of lethal ROS.55

Therefore, phosgene evacuates glutathione of lung tissue that is the principal antioxidant for neutralising ROS. Additionally, peroxynitrite is biosynthesised from NO and superoxide-radical (O2·−) by inducible NOS2 in the lung environment. Overall, peroxynitrite and ROS cause caspase cascades activation that eventually result in apoptosis.56 57 Oxidative stress triggers release of intracellular molecular chaperones such as high mobility group box-1 (HMGB-1) and heat shock proteins, which causes sterile inflammation through heterolytic and hemolytic mechanisms.58

Hydrogen sulfide (H2S)

H2S gas with spoiled eggs odour is a toxic environmental pollutant, obtained from waste water treatment, petrochemical, agricultural, industries of natural gas and factories of asphalt and rubber.59 Inhalation of H2S initially irritates the airways, and inhibits oxidative phosphorylation, leading to haemorrhagic pulmonary oedema.60 The toxicity mechanism of H2S is disruption of complex IV of electron transport chain via inhibition of cytochrome-c during aerobic glucose metabolism, which then changes to anaerobic metabolism, causing cellular toxicity via diminished ATP. This, leads to lactate accumulation due to metabolic acidosis.61 62 Overall, H2S toxicity impels oxidative stress and attenuates antioxidant system.63

The levels of antioxidants and inflammatory response are closely linked. Inflammation and oxidative stress are both significant factors that can induce apoptosis, which, in turn, plays a crucial role in regulating the immune response and contributes to various pathologies.64

Excessive exposure to atmospheric H2S can cause inflammation, oxidative stress and dysfunction of energy metabolism. H2S in the atmosphere can increase the expression of COX-2 and iNOS, which are downstream signals of NF-κB. This, in turn, stimulates the production of ROS and impairs gene expressions that are involved in energy metabolism.63 65

Ammonia (NH3)

Ammonia is a colourless gas with a sharp, pungent smell that is transported under pressure at subzero temperatures in a liquid form.66 Besides its natural origins, including the decomposition of animal excretes, decay of organic materials, soil and volcanic eruptions, ammonia is also a common agent that is released by industrial processes such as plastic and explosive synthesis and household chemical, fertiliser, refrigerant, cleaning agent.66 67 Furthermore, it plays an essential role in PM2.5 aerosol constitution via reaction with acid species in the air, that leads to air pollution.68 69

Ammonia induces oxidative stress, the release of [Ca2+], cytochrome-c and ROS from mitochondria, as well as increases mRNA levels of glutathione peroxidase, COX-2, iNOS, TNF-α and TGF-β, which are genes related to apoptosis and NF-κB protein levels. As a result, it ultimately induces mitochondrial inflammation and apoptosis.70 71 The release of cytochrome-c is accompanied by the formation of large quantities of mitochondrial ROS, which activate caspase proteins and trigger apoptosis.72 Taken together, inhalation of NH3 causes loss of mitochondrial integrity, an increase in oxidative stress, and release of calcium, ROS and cytochrome-c from mitochondria, which in turn induces apoptosis through the intrinsic pathway. Therefore, the mechanism of ammonia toxicity involves the induction of mitochondrial apoptosis and the NF-κB pathway.73

Oxides of nitrogen (NOx)

The most toxic chemical pollutant found in DE gases, produced from the combustion of fuel, is NO and NO2. These nitric oxides are non-flammable and range in colour from colourless to brown at room temperature. They also have little solubility in water.74

NOx consists of photochemical oxidants and ozone.75 Ozone reaches to an equilibration concentration, depending on solar severity, environment temperature and concentration ratio of NO2 to NO, in lack or small quantity of volatile organic compounds (VOCs) or CO. Then, NO2 is converted into O3 and NO via photolysis, and ozone is used to regenerate a NO2 molecule. These reactions cause ozone to accumulate.76 NOx in the distal airways changes to nitrous (HNO2) acids and nitric (HNO3) that lead to generating free radicals as well as oxidation of protein and peroxidation of plasma membrane lipids.10

Ozone can react with airway cells membrane such as AMs, alveolar epithelial cells (AECs) and lining fluids of airways and induces oxidative damages. This leads to inflammatory responses and bronchial hyperactivity in humans underlined by a neutrophilic inflammation.77 Recruitment of immune cells results in oxidative stress and inflammatory mediators production, for instance cytokines and free arachidonic acid, platelet activating factor and prostaglandin E2.78

Ozone exposure activates innate immune cells such as neutrophils, NK and innate lymphoid type 2 cells, which are involved in inflammatory responses Th1 and Th2.79 Exposure to ozone leads to surfactant protein D to be released, which stimulates INF-G. Also, oxidative stress response induced by ozone can activate NLRP3 inflammasome.80 Efferocytosis and phagocytic function of AMs with exposure to ozone is impaired.78 Also, it is directly cytotoxic to macrophages.81

Cyanide (CN)

Hydrogen cyanide (HCN), also known as ‘prussic acid’ (chemical warfare agents), is a pale blue fluid/gas with a poor bitter almond-like smell which is nearly 35 times more toxic than CO. This toxicant is released from fire and ignition of chemicals or artificial substances, used in construction of synthetic products, extraction of metals, biocides and in chemical laboratories.82 83 Because of its small size, HCN is mildly soluble in lipid and can penetrate the extracellular fluid of tissues, through binding to the iron inhibits mitochondrial cytochrome-c oxidase and blocking electron transport.42 83

The main mechanism of HCN’s toxicity, after inactivation of cytochrome-c oxidase, is uncoupling mitochondrial oxidative phosphorylation and in turn cellular respiration inhibition, although adequate oxygen is available. As a result, cellular metabolism converses from aerobic to anaerobic.84 Energy crisis occurs due to the decrease in ATP production, lactic acidosis and increased ROS formation in mitochondria.85

Carbon Mmonoxide (CO)

Carbon monoxide (CO) is an odourless and colourless gaseous molecule produced by the burning of carbon-containing materials in ignition engines/fireplaces in enclosed areas. It can penetrate the alveolar membrane and has an affinity for iron ions in heme that is 230–300 times greater than that of oxygen, which leads to the formation of carboxyhemoglobin. CO also reacts with cytochrome-c oxidase, cytochrome P-450, soluble guanylate cyclase, inducible nitric oxide synthase and other cellular cytochromes.86 87

By binding to iron A3 in the active site of cytochrome-c oxidase, CO inhibits oxidative phosphorylation and thus reduces ATP production in tissues. Electron transfer continues in other complexes of the electron transport chain and excessive production of ROS continues, leading to oxidative stress and cell damage.87 88

Nitrogen mustard and sulfur mustard

Both sulphur mustard, a yellow-brown oily liquid, and nitrogen mustard (a related analogue), are harmful agents. They cause pulmonary toxicity89 and acute/chronic effects which comprise dysfunction of alveolar-epithelial barrier, accumulation of activated AM, oedema, emphysema which progress to fibrosis.90 91

The main cytotoxic effects of mustards are alkylation of DNA and cross-linked nucleophilic sites in DNA, lipids and proteins, which ultimately induce poly ADP-ribose polymerase-1 (PARP-1) pathways for DNA repair.92–94 PARP-1 overactivation depletes the NAD+ reservoir.95 This depletion interrupts catabolic processes such as glycolysis, resulting in ATP exhaustion.92 94 96 The intense ATP evacuation leads to inhibition of PARP cleavage by caspase-3, and this overactivation results in cellular necrosis PARP resulting in cellular necrosis.97

The other cytotoxic mechanism is oxidative stress induced by ROS and antioxidants inactivation. Recruitment of leucocytes to the lung, overexpression of ROS-producing enzymes and mitochondrial deficiency cause massive production of ROS.98 99 Overproduction of ROS leads to oxidative damage of cellular DNA, proteins and lipids, which can subsequently be associated with cell death, inflammation and damage to respiratory system.100

Lung immune response

A pulmonary immune system consists of innate and adaptive system. It comprises non-specific parts that recognise and inactivate external agents, often without causing inflammation. The adaptive immune system includes both secreted antibodies and T cells. It can be said, the innate and adaptive immunity are interlaced.93

Two main types of lung macrophages based on location, property and function include: (1) AMs, which are in the vicinity of alveoli type I and II epithelial cells via integrins on their surface and are responsible for sampling, responding and clearing pathogens)101 102 and (2) IMs, reside in the lung interstitium between the blood compartment and alveolar epithelium.103

The role of AMs

AMs have a deterministic role in the lung microenvironment that has a relative immunologic benefit and play an important role in defending against organisms that infiltrate the lower respiratory tract, because they are extremely phagocytic and release countless mediators. Keeping the lung alveoli clear, without inducing inflammatory responses that might disrupt gas exchange in the lung, is a critical function of AMs.104 105

AMs in homeostasis condition

AMs are critical for maintenance of lung homeostasis condition, immune defence, surfactant and debris purging, pathogen recognition, onset and elimination of lung inflammation and tissue regeneration.12 106–108 In homeostatic conditions, AMs are kept in a relatively steady state through surface protein interaction (eg, CD200, SIRPα, MARCO, programme death-ligand-1 and CD47) or paracrine factors secreted by IMs and AECs to avoid unnecessary responses to inhaled particles and damage to the lungs.109 On the other hand, AMs retain a high phagocytic activity to clear particulate antigens from the respiratory system.110 Biological activity based on the microenvironment around the macrophage is carried out by two separate subpopulations including M1 and M2.111 M1 macrophages produce proinflammatory mediators and ROS that exacerbate lung injury, but M2 phenotypes have an anti-inflammatory effect that inhibits inflammation and initiates wound repair.112

Role of AMs in pulmonary diseases

Exposure to toxins triggers a set of events associated with macrophage activation, such as oxidative stress, acute injury and fibrotic response to tissue remodelling.113 This indicates that ROS generation has fundamental role and common mechanism in progression of many inflammatory diseases. While physiological concentrations play regulatory roles in cell growth, cell adhesion to other cells, differentiation, senescence, and apoptosis, excessive concentrations of ROS kill pathogens and are destructive for cells and can lead to inflammatory tissue injury.114 115 The main point considered in inflammatory diseases is the prolonged and chronic production of ROS.116 117

After the interaction of inhaled toxins with the lung surfactant, they are deposited on the alveoli, thereby preventing the metabolism of the surfactant. Also, these particles may be ingested by AMs or removed by mucociliary clearance. Prolonged stimulation of inhaled particles, phagocytosed by AMs without suppressing the immune response, causes AMs to be overactivated again and again, so that a variety of cytokines and chemokines are released which recruit inflammatory cells into the lungs, eventually triggering inflammatory response and resulting in acute lung damage or development of chronic lung disease.105

ARDS is a clinical syndrome characterised by severe inflammatory reactions in the lung, usually is secondary to pneumonia, sepsis and trauma and induced the recruitment of neutrophils and AMs (predominant) into the BALF.118 Commonly, asthma, chronic obstructive pulmonary disease (COPD) and lung fibrosis depend on polarisation of macrophage in the context of M1 and M2, with various functions and metabolic states. In fact, macrophage polarisation shift is considered as a factor of respiratory diseases development.119

Conclusion

One of the most critical tissue-resident macrophages is the pulmonary alveolar macrophages (PAMs) (heterogeneous in size and cytoplasmic contents) due to their pivotal role in the complex mechanisms of host defence. Additionally, the kinetics of AMs in the air–liquid composition of the alveolar cavity need to contribute to the proper filtration of inhaled gases, including toxic components. The defence of macrophages against toxic gases can lead to structural and functional damage to lung. Exposure to PM2.5, profoundly affects human health.

The inhaled particulates in air pollution and toxic gases can interact with AECs and immune cells within the airways stimulated when they sense ambient pollutants, as the constituents trigger cellular signalling pathways (figure 1). PAMs are highly capable of changing their function and phenotype, especially when exposed to inhaled agents. One of their abilities, compared with other resident macrophages in the body, is their power of polarisation and the occurrence of plasticity. This results from tissue damage and, at the same time, the cells' resistance to exposure to inhaled agents.

Figure 1.

Figure 1

The role of alveolar macrophages response to chemical exposure. ROS, reactive oxygen species.

The effect of inhaling irritant gases depends on the quantity and duration of exposure. Although, the clinical effects correspond to the recognised experimental immunological actions of airborne pollutants, the relative importance of specific immunological actions and different ambient pollutants to clinical pathology remains uncertain. Moreover, ROS can increase the penetrance of the alveolar endothelial cells, and oxidative stress plays a significant role in the pathogenesis of ALI and ARDS. The origin of ROS is intricate, and multiple routes are implicated in its production. Therefore, avoiding the overproduction of ROS and the declined capacity of defence in ALI/ARDS may reveal a novel scope of approaches to therapy for this disease, which despite 50 years of investigation, has not made considerable advances. A profound understanding of the immune system’s response can help develop new strategies to decrease the health damage caused by air pollution, such as using supplements, like vitamin D or antioxidants, in potentially susceptible individuals.7 120 The emphases on occupational respiratory diseases, which directly affect AMs, and the spread of urbanisation have given rise to a new wave of respiratory disorders. Special focus should be placed on the function of these cells and inhibiting the intensified reactions within them, which disrupt the hemostatic space in the alveolar region. Future studies will also aid in forming government policies to alleviate sources of air pollution with specific immunomodulatory features.

Acknowledgments

This study was a part of comprehensive project carried out by the Immunoregulation Research Center of Shahed University.

Footnotes

Contributors: MT and NM conceived the idea. All authors participated in designing, reviewing, interpreting and writing. All authors contributed to drafting and finalising the manuscript and approved the final version for submission.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Competing interests: None declared.

Provenance and peer review: Not commissioned; externally peer reviewed.

Ethics statements

Patient consent for publication

Not applicable.

References

  • 1.Ekici A, Ekici M, Kurtipek E, et al. Obstructive airway diseases in women exposed to Biomass smoke. Environ Res 2005;99:93–8. 10.1016/j.envres.2005.01.004 [DOI] [PubMed] [Google Scholar]
  • 2.World Health Organization . Burden of disease from the joint effects of household and ambient air pollution for 2016. World Health Organization, 2018. [Google Scholar]
  • 3.Chaudhuri N, Jary H, Lea S, et al. Diesel exhaust particle exposure in vitro alters monocyte differentiation and function. PLoS One 2012;7:e51107. 10.1371/journal.pone.0051107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Anderson JO, Thundiyil JG, Stolbach A. Clearing the air: a review of the effects of particulate matter air pollution on human health. J Med Toxicol 2012;8:166–75. 10.1007/s13181-011-0203-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Srimuruganandam B, Shiva Nagendra SM. Source characterization of Pm10 and Pm2. 5 mass using a chemical mass balance model at urban roadside. Sci Total Environ 2012;433:8–19. 10.1016/j.scitotenv.2012.05.082 [DOI] [PubMed] [Google Scholar]
  • 6.Cohen SB, Gern BH, Delahaye JL, et al. Alveolar Macrophages provide an early Mycobacterium tuberculosis niche and initiate dissemination. Cell Host & Microbe 2018;24:439–446. 10.1016/j.chom.2018.08.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Glencross DA, Ho T-R, Camiña N, et al. Air pollution and its effects on the immune system. Free Radic Biol Med 2020;151:56–68. 10.1016/j.freeradbiomed.2020.01.179 [DOI] [PubMed] [Google Scholar]
  • 8.Pitocco D, Tesauro M, Alessandro R, et al. Oxidative stress in diabetes: implications for vascular and other complications. Int J Mol Sci 2013;14:21525–50. 10.3390/ijms141121525 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Boraschi D, Italiani P, Palomba R, et al. Nanoparticles and innate immunity: new perspectives on host defence. Semin Immunol 2017;34:33–51. 10.1016/j.smim.2017.08.013 [DOI] [PubMed] [Google Scholar]
  • 10.Gorguner M, Akgun M. Acute inhalation injury. EAJM 2010;42:28–35. 10.5152/eajm.2010.09 Available: http://www.eajm.org/content.php3?id=38 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Wong J, Magun BE, Wood LJ. Lung inflammation caused by inhaled Toxicants: a review. Int J Chron Obstruct Pulmon Dis 2016;11:1391–401. 10.2147/COPD.S106009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Joshi N, Walter JM, Misharin AV. Alveolar Macrophages. Cell Immunol 2018;330:86–90. 10.1016/j.cellimm.2018.01.005 [DOI] [PubMed] [Google Scholar]
  • 13.Lee H, Abston E, Zhang D, et al. Extracellular Vesicle: an emerging mediator of Intercellular Crosstalk in lung inflammation and injury. Front Immunol 2018;9:924. 10.3389/fimmu.2018.00924 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Piao MJ, Ahn MJ, Kang KA, et al. Particulate matter 2.5 damages skin cells by inducing oxidative stress, subcellular Organelle dysfunction, and apoptosis. Arch Toxicol 2018;92:2077–91. 10.1007/s00204-018-2197-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hoenderdos K, Condliffe A. The neutrophil in chronic obstructive pulmonary disease. too little, too late or too much, too soon Am J Respir Cell Mol Biol 2013;48:531–9. 10.1165/rcmb.2012-0492TR [DOI] [PubMed] [Google Scholar]
  • 16.Meijer M, Rijkers GT, van Overveld FJ. Neutrophils and emerging targets for treatment in chronic obstructive pulmonary disease. Expert Rev Clin Immunol 2013;9:1055–68. 10.1586/1744666X.2013.851347 [DOI] [PubMed] [Google Scholar]
  • 17.Lawal AO, Davids LM, Marnewick JL. Diesel exhaust particles and endothelial cells dysfunction: an update. Toxicol In Vitro 2016;32:92–104. 10.1016/j.tiv.2015.12.015 [DOI] [PubMed] [Google Scholar]
  • 18.Lawal AO. Diesel exhaust particles and the induction of macrophage activation and dysfunction. Inflammation 2018;41:356–63. 10.1007/s10753-017-0682-6 [DOI] [PubMed] [Google Scholar]
  • 19.Mazzarella G, Ferraraccio F, Prati MV, et al. Effects of diesel exhaust particles on human lung epithelial cells: an in vitro study. Respiratory Medicine 2007;101:1155–62. 10.1016/j.rmed.2006.11.011 [DOI] [PubMed] [Google Scholar]
  • 20.Sarkar S, Song Y, Sarkar S, et al. Suppression of the NF-ΚB pathway by diesel exhaust particles impairs human antimycobacterial immunity. J Immunol 2012;188:2778–93. 10.4049/jimmunol.1101380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004;56:515–48. 10.1124/pr.56.4.2 [DOI] [PubMed] [Google Scholar]
  • 22.OPCW . Organisation for the prohibition of chemical weapons Ricin fact sheet. 2014.
  • 23.Sandvig K, van Deurs B. Transport of protein toxins into cells: pathways used by Ricin, cholera toxin and Shiga toxin. FEBS Lett 2002;529:49–53. 10.1016/s0014-5793(02)03182-4 [DOI] [PubMed] [Google Scholar]
  • 24.Moshiri M, Etemad L, Balali-Mood M. The Biowarfare agent Ricin. Biological Toxins and Bioterrorism, Series: Toxinology 2015;1:43–59. 10.1007/978-94-007-5869-8 [DOI] [Google Scholar]
  • 25.Rong Y, Torres-Velez FJ, Ehrbar D, et al. An Intranasally administered Monoclonal antibody cocktail Abrogates Ricin toxin-induced pulmonary tissue damage and inflammation. Human Vaccines & Immunotherapeutics 2020;16:793–807. 10.1080/21645515.2019.1664243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Guo Z, Wang Z, Meng S, et al. Effects of Ricin on primary pulmonary alveolar Macrophages. J Int Med Res 2019;47:3763–77. 10.1177/0300060519842959 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Sowa-Rogozińska N, Sominka H, Nowakowska-Gołacka J, et al. Intracellular transport and cytotoxicity of the protein toxin Ricin. Toxins (Basel) 2019;11:350. 10.3390/toxins11060350 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Meneguelli de Souza LC, Carvalho L de, Araújo JS, et al. Cell toxicity by Ricin and elucidation of mechanism of Ricin inactivation. Int J Biol Macromol 2018;113:821–8. 10.1016/j.ijbiomac.2018.03.024 [DOI] [PubMed] [Google Scholar]
  • 29.Greenfield RA, Brown BR, Hutchins JB, et al. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci 2002;323:326–40. 10.1097/00000441-200206000-00005 [DOI] [PubMed] [Google Scholar]
  • 30.Tashkin DP, Roth MD. Pulmonary effects of inhaled Cannabis smoke. Am J Drug Alcohol Abuse 2019;45:596–609. 10.1080/00952990.2019.1627366 [DOI] [PubMed] [Google Scholar]
  • 31.Cabral GA, Griffin-Thomas L. Emerging role of the Cannabinoid receptor Cb2 in immune regulation: therapeutic prospects for Neuroinflammation. Expert Rev Mol Med 2009;11:e3. 10.1017/S1462399409000957 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Tashkin DP. Marijuana and lung disease. Chest 2018;154:653–63. 10.1016/j.chest.2018.05.005 [DOI] [PubMed] [Google Scholar]
  • 33.Rubovitch V, Gafni M, Sarne Y. The involvement of VEGF receptors and MAPK in the Cannabinoid potentiation of Ca2+ flux into N18Tg2 neuroblastoma cells. Brain Res Mol Brain Res 2004;120:138–44. 10.1016/j.molbrainres.2003.10.012 [DOI] [PubMed] [Google Scholar]
  • 34.Han KH, Lim S, Ryu J, et al. Cb1 and Cb2 Cannabinoid receptors Differentially regulate the production of reactive oxygen species by Macrophages. Cardiovasc Res 2009;84:378–86. 10.1093/cvr/cvp240 [DOI] [PubMed] [Google Scholar]
  • 35.Pavan C, Delle Piane M, Gullo M, et al. The puzzling issue of silica toxicity: are Silanols bridging the gaps between surface States and Pathogenicity? particle and fibre toxicology Part Fibre Toxicol 2019;16:1–10. 10.1186/s12989-019-0315-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Leung CC, Yu ITS, Chen W. Silicosis. Lancet 2012;379:2008–18. 10.1016/S0140-6736(12)60235-9 [DOI] [PubMed] [Google Scholar]
  • 37.Malik A, Kanneganti T-D. Inflammasome activation and assembly at a glance. J Cell Sci 2017;130:3955–63. 10.1242/jcs.207365 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Kelley N, Jeltema D, Duan Y, et al. The Nlrp3 Inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 2019;20:3328. 10.3390/ijms20133328 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Hamilton RF, Thakur SA, Holian A. Silica binding and toxicity in alveolar Macrophages. Free Radic Biol Med 2008;44:1246–58. 10.1016/j.freeradbiomed.2007.12.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Yang M, Qian X, Wang N, et al. Inhibition of MARCO ameliorates silica-induced pulmonary fibrosis by regulating epithelial-Mesenchymal transition. Toxicol Lett 2019;301:64–72. 10.1016/j.toxlet.2018.10.031 [DOI] [PubMed] [Google Scholar]
  • 41.Habre R, Coull B, Moshier E, et al. Sources of indoor air pollution in New York City residences of asthmatic children. J Expo Sci Environ Epidemiol 2014;24:269–78. 10.1038/jes.2013.74 [DOI] [PubMed] [Google Scholar]
  • 42.Saeed O, Boyer NL, Pamplin JC, et al. Inhalation injury and toxic industrial chemical exposure. Mil Med 2018;183:130–2. 10.1093/milmed/usy073 [DOI] [PubMed] [Google Scholar]
  • 43.Gupta K, Mehrotra M, Kumar P, et al. Smoke inhalation injury: Etiopathogenesis, diagnosis, and management. Indian J Crit Care Med 2018;22:180–8. 10.4103/ijccm.IJCCM_460_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Anderson D, Macnee W. Targeted treatment in COPD: a multi-system approach for a multi-system disease. Int J Chron Obstruct Pulmon Dis 2009;4:321–35. 10.2147/copd.s2999 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Nos RCR . Hydrochloric acid. [Google Scholar]
  • 46.Tuck SA, Ramos-Barbón D, Campbell H, et al. Time course of airway remodelling after an acute chlorine gas exposure in mice. Respir Res 2008;9:61. 10.1186/1465-9921-9-61 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.White CW, Martin JG. Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models. Proc Am Thorac Soc 2010;7:257–63. 10.1513/pats.201001-008SM [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Martin JG, Campbell HR, Iijima H, et al. Chlorine-induced injury to the Airways in mice. Am J Respir Crit Care Med 2003;168:568–74. 10.1164/rccm.200201-021OC [DOI] [PubMed] [Google Scholar]
  • 49.Balakrishna S, Song W, Achanta S, et al. Trpv4 inhibition Counteracts edema and inflammation and improves pulmonary function and oxygen saturation in chemically induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2014;307:L158–72. 10.1152/ajplung.00065.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Carlisle M, Lam A, Svendsen ER, et al. Chlorine-induced cardiopulmonary injury. Ann N Y Acad Sci 2016;1374:159–67. 10.1111/nyas.13091 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Jurkuvenaite A, Benavides GA, Komarova S, et al. Upregulation of Autophagy decreases chlorine-induced mitochondrial injury and lung inflammation. Free Radic Biol Med 2015;85:83–94. 10.1016/j.freeradbiomed.2015.03.039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Pauluhn J. Concentration × time analyses of sensory irritants Revisited: weight of evidence or the toxic load approach. that is the question. Toxicol Lett 2019;316:94–108. 10.1016/j.toxlet.2019.09.001 [DOI] [PubMed] [Google Scholar]
  • 53.Pauluhn J. Acute nose-only exposure of rats to phosgene. part I: Concentration× time dependence of Lc50S, nonlethal-threshold concentrations, and analysis of breathing patterns. Inhal Toxicol 2006;18:423–35. 10.1080/08958370600563680 [DOI] [PubMed] [Google Scholar]
  • 54.Gupta RC. Handbook of toxicology of chemical warfare agents. Academic Press, 2020. [Google Scholar]
  • 55.Holmes WW, Keyser BM, Paradiso DC, et al. Conceptual approaches for treatment of phosgene inhalation-induced lung injury. Toxicol Lett 2016;244:8–20. 10.1016/j.toxlet.2015.10.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Hobson ST, Richieri RA, Parseghian MH. Phosgene: toxicology, animal models, and medical countermeasures. Toxicology Mechanisms and Methods 2021;31:293–307. 10.1080/15376516.2021.1885544 [DOI] [PubMed] [Google Scholar]
  • 57.Chang C-C, Chen S-D, Lin T-K, et al. Heat shock protein 70 protects against seizure-induced neuronal cell death in the hippocampus following experimental status epilepticus via inhibition of nuclear factor-ΚB activation-induced nitric oxide synthase II expression. Neurobiol Dis 2014;62:241–9. 10.1016/j.nbd.2013.10.012 [DOI] [PubMed] [Google Scholar]
  • 58.Lugrin J, Rosenblatt-Velin N, Parapanov R, et al. The role of oxidative stress during inflammatory processes. Biol Chem 2014;395:203–30. 10.1515/hsz-2013-0241 [DOI] [PubMed] [Google Scholar]
  • 59.Szabo C. A Timeline of hydrogen sulfide (H2S) research: from environmental toxin to biological mediator. Biochem Pharmacol 2018;149:5–19. 10.1016/j.bcp.2017.09.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Frame MH, Schandl CA. A case example of asphyxia due to occupational exposure to airborne chemicals and review of workplace fatalities. J Forensic Sci 2015;60:521–4. 10.1111/1556-4029.12695 [DOI] [PubMed] [Google Scholar]
  • 61.Sawaya A, Menezes RG. Hydrogen sulfide toxicity. StatPearls 2020. [PubMed] [Google Scholar]
  • 62.Szabo C, Ransy C, Módis K, et al. Regulation of mitochondrial Bioenergetic function by hydrogen sulfide. part I. biochemical and physiological mechanisms. Br J Pharmacol 2014;171:2099–122. 10.1111/bph.12369 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Kim S-H, Kim J-H, Park M-A, et al. The toxic effects of ammonia exposure on antioxidant and immune responses in Rockfish, Sebastes Schlegelii during thermal stress. Environ Toxicol Pharmacol 2015;40:954–9. 10.1016/j.etap.2015.10.006 [DOI] [PubMed] [Google Scholar]
  • 64.Harrison L, Brown C, Afonso C, et al. Early occurrence of apoptosis in Lymphoid tissues from chickens infected with strains of Newcastle disease virus of varying virulence. J Comp Pathol 2011;145:327–35. 10.1016/j.jcpa.2011.03.005 [DOI] [PubMed] [Google Scholar]
  • 65.Chi Q, Chi X, Hu X, et al. The effects of atmospheric hydrogen sulfide on peripheral blood lymphocytes of chickens: perspectives on inflammation, oxidative stress and energy metabolism. Environ Res 2018;167:1–6. 10.1016/j.envres.2018.06.051 [DOI] [PubMed] [Google Scholar]
  • 66.Krewski D, Bishop E, Bruckner J, et al. Acute exposure guideline levels for selected airborne chemicals.(9780309290258). Washington, DC: The National Academies Press, 2013. [Google Scholar]
  • 67.Ghaly A, MacDonald K. Development and testing of an ammonia removal unit from the exhaust gas of a manure drying system. Am J Environ Sci 2013;9:51–61. 10.3844/ajessp.2013.51.61 [DOI] [Google Scholar]
  • 68.Updyke KM, Nguyen TB, Nizkorodov SA. Formation of Brown carbon via reactions of ammonia with secondary organic aerosols from Biogenic and Anthropogenic precursors. Atmospheric Environment 2012;63:22–31. 10.1016/j.atmosenv.2012.09.012 [DOI] [Google Scholar]
  • 69.Bicer Y, Dincer I. Life cycle assessment of ammonia utilization in city transportation and power generation. J Clean Product 2018;170:1594–601. 10.1016/j.jclepro.2017.09.243 [DOI] [Google Scholar]
  • 70.Chen D, Ning F, Zhang J, et al. NF-ΚB pathway took part in the development of apoptosis mediated by miR-15A and oxidative stress via mitochondrial pathway in ammonia-treated chicken splenic lymphocytes. Sci Total Environ 2020;729:S0048-9697(20)32534-1. 10.1016/j.scitotenv.2020.139017 [DOI] [PubMed] [Google Scholar]
  • 71.Ali R, Mittal G, Sultana S, et al. Ameliorative potential of alpha-Ketoglutaric acid (AKG) on acute lung injuries induced by ammonia inhalation in rats. Exp Lung Res 2012;38:435–44. 10.3109/01902148.2012.721859 [DOI] [PubMed] [Google Scholar]
  • 72.Nguyen C, Pandey S. Exploiting mitochondrial Vulnerabilities to trigger apoptosis selectively in cancer cells. Cancers 2019;11:916. 10.3390/cancers11070916 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Shah SWA, Chen J, Han Q, et al. Ammonia inhalation impaired immune function and mitochondrial integrity in the broilers Bursa of Fabricius: implication of oxidative stress and apoptosis. Ecotoxicol Environ Saf 2020;190:S0147-6513(19)31409-5. 10.1016/j.ecoenv.2019.110078 [DOI] [PubMed] [Google Scholar]
  • 74.Likhanov VA, Lopatin OP. Research of high-speed diesel engines of small dimension on Biofuel. J Phys: Conf Ser 2019;1399:055016. 10.1088/1742-6596/1399/5/055016 [DOI] [Google Scholar]
  • 75.Lopatin OP. Phenomenology of nitrogen oxides formation in a gas-diesel engine. J Phys: Conf Ser 2020;1515:042009. 10.1088/1742-6596/1515/4/042009 [DOI] [Google Scholar]
  • 76.Zhang JJ, Wei Y, Fang Z. Ozone pollution: a major health hazard worldwide. Front Immunol 2019;10:2518. 10.3389/fimmu.2019.02518 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Mudway IS, Kelly FJ. Ozone and the lung: a sensitive issue. Mol Aspects Med 2000;21:1–48. 10.1016/s0098-2997(00)00003-0 [DOI] [PubMed] [Google Scholar]
  • 78.Wiegman CH, Li F, Ryffel B, et al. Oxidative stress in ozone-induced chronic lung inflammation and emphysema: A facet of chronic obstructive pulmonary disease. Front Immunol 2020;11:1957. 10.3389/fimmu.2020.01957 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Ge MQ, Kokalari B, Flayer CH, et al. Cutting edge: role of NK cells and surfactant protein D in Dendritic cell lymph node homing: effects of ozone exposure. J Immunol 2016;196:553–7. 10.4049/jimmunol.1403042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Michaudel C, Couturier-Maillard A, Chenuet P, et al. Inflammasome, IL-1 and inflammation in ozone-induced lung injury. Am J Clin Exp Immunol 2016;5:33–40. [PMC free article] [PubMed] [Google Scholar]
  • 81.Hollingsworth JW, Kleeberger SR, Foster WM. Ozone and pulmonary innate immunity. Proc Am Thorac Soc 2007;4:240–6. 10.1513/pats.200701-023AW [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Hull TR. Bench-scale generation of fire effluents: Chapter 12. 2010. [Google Scholar]
  • 83.Crewe RJ, Lyons AG, Hull TR, et al. Asphyxiant yields from common polymers in under-ventilated fires in the large Instrumented fire enclosure (LIFE). Fire Safety Journal 2017;91:982–8. 10.1016/j.firesaf.2017.03.026 [DOI] [Google Scholar]
  • 84.Ogbuagu EO, Airaodion AI, Okoroukwu VN, et al. n.d. Cyanide toxicity: the good, the bad and the ugly.
  • 85.Srinivasan S, Avadhani NG. Cytochrome C oxidase dysfunction in oxidative stress. Free Radic Biol Med 2012;53:1252–63. 10.1016/j.freeradbiomed.2012.07.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Hoetzel A, Schmidt R, Vallbracht S, et al. Carbon Monoxide prevents ventilator induced lung injury via Caveolin-1. critical care medicine. Crit Care Med 2009;37:1708–15. 10.1097/CCM.0b013e31819efa31 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Rose JJ, Wang L, Xu Q, et al. Carbon Monoxide poisoning: pathogenesis, management, and future directions of therapy. Am J Respir Crit Care Med 2017;195:596–606. 10.1164/rccm.201606-1275CI [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Lo Iacono L, Boczkowski J, Zini R, et al. A carbon Monoxide-releasing molecule (CORM-3) Uncouples mitochondrial respiration and modulates the production of reactive oxygen species. Free Radical Biology and Medicine 2011;50:1556–64. 10.1016/j.freeradbiomed.2011.02.033 [DOI] [PubMed] [Google Scholar]
  • 89.Malaviya R, Sunil VR, Venosa A, et al. Macrophages and inflammatory mediators in pulmonary injury induced by mustard Vesicants. Ann N Y Acad Sci 2016;1374:168–75. 10.1111/nyas.13123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Balali-Mood M, Hefazi M. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol 2005;19:297–315. 10.1111/j.1472-8206.2005.00325.x Available: http://www.blackwell-synergy.com/toc/fcp/19/3 [DOI] [PubMed] [Google Scholar]
  • 91.Razavi SM, Ghanei M, Salamati P, et al. Long-term effects of mustard gas on respiratory system of Iranian veterans after Iraq-Iran war: a review. Chin J Traumatol 2013;16:163–8. [PubMed] [Google Scholar]
  • 92.Ruszkiewicz JA, Bürkle A, Mangerich A. NAD+ in sulfur mustard toxicity. Toxicology Letters 2020;324:95–103. 10.1016/j.toxlet.2020.01.024 [DOI] [PubMed] [Google Scholar]
  • 93.Sadeghi S, Tapak M, Ghazanfari T, et al. A review of sulfur mustard-induced pulmonary Immunopathology: an alveolar macrophage approach. Toxicol Lett 2020;333:115–29. 10.1016/j.toxlet.2020.07.035 [DOI] [PubMed] [Google Scholar]
  • 94.Venosa A, Malaviya R, Choi H, et al. Characterization of distinct macrophage subpopulations during nitrogen mustard–induced lung injury and fibrosis. Am J Respir Cell Mol Biol 2016;54:436–46. 10.1165/rcmb.2015-0120OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006;12:440–50. 10.1016/j.molmed.2006.07.007 [DOI] [PubMed] [Google Scholar]
  • 96.Martens ME, Smith WJ. The role of NAD+ depletion in the mechanism of sulfur mustard–induced metabolic injury. Cutan Ocul Toxicol 2008;27:41–53. 10.1080/15569520701863696 [DOI] [PubMed] [Google Scholar]
  • 97.Nguewa PA, Fuertes MA, Alonso C, et al. Pharmacological modulation of poly (ADP-ribose) polymerase-mediated cell death: exploitation in cancer chemotherapy. Mol Pharmacol 2003;64:1007–14. 10.1124/mol.64.5.1007 [DOI] [PubMed] [Google Scholar]
  • 98.Nourani MR, Mahmoodzadeh Hosseini H, Azimzadeh Jamalkandi S, et al. Cellular and molecular mechanisms of acute exposure to sulfur mustard: a systematic review. J Recept Signal Transduct Res 2017;37:200–16. 10.1080/10799893.2016.1212374 [DOI] [PubMed] [Google Scholar]
  • 99.Beigi Harchegani A, Tahmasbpour E, Borna H, et al. Free radical production and oxidative stress in lung tissue of patients exposed to sulfur mustard: an overview of cellular and molecular mechanisms. Chem Res Toxicol 2018;31:211–22. 10.1021/acs.chemrestox.7b00315 [DOI] [PubMed] [Google Scholar]
  • 100.Chow C-W, Herrera Abreu MT, Suzuki T, et al. Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol 2003;29:427–31. 10.1165/rcmb.F278 [DOI] [PubMed] [Google Scholar]
  • 101.Hussell T, Bell TJ. Alveolar Macrophages: plasticity in a tissue-specific context. Nat Rev Immunol 2014;14:81–93. 10.1038/nri3600 [DOI] [PubMed] [Google Scholar]
  • 102.Viola A, Munari F, Sánchez-Rodríguez R, et al. The metabolic signature of macrophage responses. Front Immunol 2019;10:1462. 10.3389/fimmu.2019.01462 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Misharin AV, Scott Budinger GR, Perlman H. The lung macrophage: a jack of all trades. Am J Respir Crit Care Med 2011;184:497–8. 10.1164/rccm.201107-1343ED [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Laskin DL. Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem Res Toxicol 2009;22:1376–85. 10.1021/tx900086v [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Hogg JC, van Eeden S. Pulmonary and systemic response to atmospheric pollution. Respirology 2009;14:336–46. 10.1111/j.1440-1843.2009.01497.x [DOI] [PubMed] [Google Scholar]
  • 106.Byrne AJ, Mathie SA, Gregory LG, et al. Pulmonary Macrophages: key players in the innate defence of the Airways. Thorax 2015;70:1189–96. 10.1136/thoraxjnl-2015-207020 [DOI] [PubMed] [Google Scholar]
  • 107.Ruaro B, Salton F, Braga L, et al. The history and mystery of alveolar epithelial type II cells: focus on their physiologic and pathologic role in lung. Int J Mol Sci 2021;22:2566. 10.3390/ijms22052566 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Lambrecht BN, Hammad H, Fahy JV. The Cytokines of asthma. Immunity 2019;50:975–91. 10.1016/j.immuni.2019.03.018 [DOI] [PubMed] [Google Scholar]
  • 109.Divangahi M, King IL, Pernet E. Alveolar Macrophages and type I IFN in airway homeostasis and immunity. Trends Immunol 2015;36:307–14. 10.1016/j.it.2015.03.005 [DOI] [PubMed] [Google Scholar]
  • 110.Patel VI, Booth JL, Duggan ES, et al. Transcriptional classification and functional characterization of human airway macrophage and Dendritic cell Subsets. J Immunol 2017;198:1183–201. 10.4049/jimmunol.1600777 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Malaviya R, Sunil VR, Cervelli J, et al. Inflammatory effects of inhaled sulfur mustard in rat lung. Toxicol Appl Pharmacol 2010;248:89–99. 10.1016/j.taap.2010.07.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 2014;6:13. 10.12703/P6-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Sadeghi S, Mosaffa N, Hashemi SM, et al. The immunomodulatory effects of Mesenchymal stem cells on long term pulmonary complications in an animal model exposed to a sulfur mustard analog. Int Immunopharmacol 2020;80:S1567-5769(19)31294-9. 10.1016/j.intimp.2019.105879 [DOI] [PubMed] [Google Scholar]
  • 114.Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47–95. 10.1152/physrev.00018.2001 [DOI] [PubMed] [Google Scholar]
  • 115.Mittal M, Siddiqui MR, Tran K, et al. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 2014;20:1126–67. 10.1089/ars.2012.5149 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Martinon F, Mayor A, Tschopp J. The Inflammasomes: guardians of the body. Annu Rev Immunol 2009;27:229–65. 10.1146/annurev.immunol.021908.132715 Available: https://www.annualreviews.org/toc/immunol/27/1 [DOI] [PubMed] [Google Scholar]
  • 117.Satoh T, Otsuka A, Contassot E, et al. The Inflammasome and IL-1Β: implications for the treatment of inflammatory diseases. Immunotherapy 2015;7:243–54. 10.2217/imt.14.106 [DOI] [PubMed] [Google Scholar]
  • 118.Dong H, Li J, Lv Y, et al. Comparative analysis of the alveolar macrophage Proteome in ALI/ARDS patients between the Exudative phase and recovery phase. BMC Immunol 2013;14:25. 10.1186/1471-2172-14-25 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Boorsma CE, Draijer C, Melgert BN. Macrophage heterogeneity in respiratory diseases. Mediators Inflamm 2013;2013:769214. 10.1155/2013/769214 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Wang L, Zhou Z, Li D, et al. The Modifiable effect of vitamin D in the association between long-term exposure to ambient air pollution and Glycosylated hemoglobin in patients with hypertension. Nutrition 2023;107:S0899-9007(22)00332-X. 10.1016/j.nut.2022.111920 [DOI] [PubMed] [Google Scholar]

Articles from BMJ Open Respiratory Research are provided here courtesy of BMJ Publishing Group

RESOURCES